Metastatic Prostate Cancer Treatment Market Report

Global and Region Metastatic Prostate Cancer Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：195
  • REPORT CODE：GMM991791
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Metastatic Prostate Cancer Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Metastatic Prostate Cancer Treatmentmarket, defines the market attractiveness level of Metastatic Prostate Cancer Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Metastatic Prostate Cancer Treatment industry, describes the types of Metastatic Prostate Cancer Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Metastatic Prostate Cancer Treatment market and the development prospects and opportunities of Metastatic Prostate Cancer Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Metastatic Prostate Cancer Treatment market in Chapter 13.

    By Player:

    • VasGene Therapeutics Inc

    • eFFECTOR Therapeutics

    • Immunomedics(Gilead Sciences Inc)

    • Telix Pharmaceuticals

    • Zenith Epigenetics Ltd

    • AB Science

    • Arvinas Inc

    • SeleXel

    • BeiGene

    • Genentech

    • Amgen

    • Myovant Biosciences

    By Type:

    • Mono

    • Combination

    • Mono/Combination

    By End-User:

    • Hospital

    • Drug Store

    • Online Pharmacy

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Metastatic Prostate Cancer Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Metastatic Prostate Cancer Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Metastatic Prostate Cancer Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Metastatic Prostate Cancer Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Metastatic Prostate Cancer Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    • 7.2 United States Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    • 7.3 Europe Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    • 7.4 China Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    • 7.5 Japan Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    • 7.6 India Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    • 7.7 South Korea Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    8 Region and Country-wise Metastatic Prostate Cancer Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 8.4 China Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 8.6 India Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    9 Global Metastatic Prostate Cancer Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Metastatic Prostate Cancer Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Mono Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Combination Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Mono/Combination Consumption and Growth Rate (2017-2022)

    • 9.2 Global Metastatic Prostate Cancer Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Drug Store Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    10 Global Metastatic Prostate Cancer Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Mono Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Combination Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Mono/Combination Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Drug Store Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    11 Global Metastatic Prostate Cancer Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Metastatic Prostate Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Metastatic Prostate Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Metastatic Prostate Cancer Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Metastatic Prostate Cancer Treatment Market Competitive Analysis

    • 14.1 VasGene Therapeutics Inc

      • 14.1.1 VasGene Therapeutics Inc Company Details

      • 14.1.2 VasGene Therapeutics Inc Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 VasGene Therapeutics Inc Metastatic Prostate Cancer Treatment Product and Service

    • 14.2 eFFECTOR Therapeutics

      • 14.2.1 eFFECTOR Therapeutics Company Details

      • 14.2.2 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product and Service

    • 14.3 Immunomedics(Gilead Sciences Inc)

      • 14.3.1 Immunomedics(Gilead Sciences Inc) Company Details

      • 14.3.2 Immunomedics(Gilead Sciences Inc) Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Immunomedics(Gilead Sciences Inc) Metastatic Prostate Cancer Treatment Product and Service

    • 14.4 Telix Pharmaceuticals

      • 14.4.1 Telix Pharmaceuticals Company Details

      • 14.4.2 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product and Service

    • 14.5 Zenith Epigenetics Ltd

      • 14.5.1 Zenith Epigenetics Ltd Company Details

      • 14.5.2 Zenith Epigenetics Ltd Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Zenith Epigenetics Ltd Metastatic Prostate Cancer Treatment Product and Service

    • 14.6 AB Science

      • 14.6.1 AB Science Company Details

      • 14.6.2 AB Science Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AB Science Metastatic Prostate Cancer Treatment Product and Service

    • 14.7 Arvinas Inc

      • 14.7.1 Arvinas Inc Company Details

      • 14.7.2 Arvinas Inc Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Arvinas Inc Metastatic Prostate Cancer Treatment Product and Service

    • 14.8 SeleXel

      • 14.8.1 SeleXel Company Details

      • 14.8.2 SeleXel Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 SeleXel Metastatic Prostate Cancer Treatment Product and Service

    • 14.9 BeiGene

      • 14.9.1 BeiGene Company Details

      • 14.9.2 BeiGene Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 BeiGene Metastatic Prostate Cancer Treatment Product and Service

    • 14.10 Genentech

      • 14.10.1 Genentech Company Details

      • 14.10.2 Genentech Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Genentech Metastatic Prostate Cancer Treatment Product and Service

    • 14.11 Amgen

      • 14.11.1 Amgen Company Details

      • 14.11.2 Amgen Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Amgen Metastatic Prostate Cancer Treatment Product and Service

    • 14.12 Myovant Biosciences

      • 14.12.1 Myovant Biosciences Company Details

      • 14.12.2 Myovant Biosciences Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Metastatic Prostate Cancer Treatment

    • Figure Metastatic Prostate Cancer Treatment Picture

    • Table Global Metastatic Prostate Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Metastatic Prostate Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Metastatic Prostate Cancer Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Metastatic Prostate Cancer Treatment Consumption by Country (2017-2022)

    • Figure United States Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Metastatic Prostate Cancer Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mono Consumption and Growth Rate (2017-2022)

    • Figure Global Combination Consumption and Growth Rate (2017-2022)

    • Figure Global Mono/Combination Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Store Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Mono Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Combination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mono/Combination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Store Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Metastatic Prostate Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Metastatic Prostate Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table VasGene Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table VasGene Therapeutics Inc Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table VasGene Therapeutics Inc Metastatic Prostate Cancer Treatment Product and Service

    • Table eFFECTOR Therapeutics (Foundation Year, Company Profile and etc.)

    • Table eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product and Service

    • Table Immunomedics(Gilead Sciences Inc) (Foundation Year, Company Profile and etc.)

    • Table Immunomedics(Gilead Sciences Inc) Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunomedics(Gilead Sciences Inc) Metastatic Prostate Cancer Treatment Product and Service

    • Table Telix Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product and Service

    • Table Zenith Epigenetics Ltd (Foundation Year, Company Profile and etc.)

    • Table Zenith Epigenetics Ltd Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zenith Epigenetics Ltd Metastatic Prostate Cancer Treatment Product and Service

    • Table AB Science (Foundation Year, Company Profile and etc.)

    • Table AB Science Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AB Science Metastatic Prostate Cancer Treatment Product and Service

    • Table Arvinas Inc (Foundation Year, Company Profile and etc.)

    • Table Arvinas Inc Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arvinas Inc Metastatic Prostate Cancer Treatment Product and Service

    • Table SeleXel (Foundation Year, Company Profile and etc.)

    • Table SeleXel Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table SeleXel Metastatic Prostate Cancer Treatment Product and Service

    • Table BeiGene (Foundation Year, Company Profile and etc.)

    • Table BeiGene Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table BeiGene Metastatic Prostate Cancer Treatment Product and Service

    • Table Genentech (Foundation Year, Company Profile and etc.)

    • Table Genentech Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Metastatic Prostate Cancer Treatment Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Metastatic Prostate Cancer Treatment Product and Service

    • Table Myovant Biosciences (Foundation Year, Company Profile and etc.)

    • Table Myovant Biosciences Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Myovant Biosciences Metastatic Prostate Cancer Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US